CNTB Stock Price
Connect Biopharma Holdings Limited
CNTB stock price is $0.87 (-1.21% on the day), giving Connect Biopharma Holdings Limited a market cap of $55.46M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
CNTB Stock Overview
- Price
- $0.87
- Previous close
- $0.88
- Open
- $0.87
- Market cap
- $55.46M
- P/E ratio
- -3.5
- 52-week range
- $0.89 - $3.82
- 1-year price target
- $5.88
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSD
- MarketXLS Rank
- 19
About Connect Biopharma Holdings Limited
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma, currently under Phase 3 studies; and icanbelimod (formerly CBP-307), an oral small molecule Sphingosine 1-Phosphate Receptor 1 modulator, currently under Phase 2 clinical for the treatment of ulcerative colitis and Crohn's disease. The company was founded in 2012 and is based in San Diego, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CNTB | $0.87 | -1.2% | 1.05M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Connect Biopharma Holdings Limited Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW